Changes in the Level of Antiphospholipid Antibodies (Anticardiolipin and Anti-β2-Glycoprotein-I) and Thromboembolic Indices in COVID-19 Patients during 3 Weeks

Changes in the Level of Antiphospholipid Antibodies (Anticardiolipin and Anti-β2-Glycoprotein-I) and Thromboembolic Indices in COVID-19 Patients during 3 Weeks

Introduction: COVID-19 is a respiratory disease caused by infection with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). Thrombotic complications appear to be of particular importance in patients with COVID-19. This study aimed to investigate Changes in the level of Antiphospholipid an...

Full description

Bibliographic Details
Main Authors: Somayeh Haghighipour, Mansour Salesi, Fereshteh Keikhaei, Mohammad J. Tarrahi, Zahra Khani, Hassan Salehi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-03-01
Series:International Journal of Preventive Medicine
Subjects:
anticardiolipin
anti-β2-glycoprotein-i
covid-19
thrombosis
Online Access:https://journals.lww.com/10.4103/ijpvm.ijpvm_377_21

Internet

https://journals.lww.com/10.4103/ijpvm.ijpvm_377_21

Similar Items